Search for a report

ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

The Asia Pacific pharmaceutical continuous manufacturing market is set to project a CAGR of 10.99% during the forecast period, 2021-2028. The growing investment in the pharmaceutical and biopharmaceutical industries and the thriving contract research organization (CRO) and contract manufacturing organization (CMO) are assessed to propel market growth.

ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous System, Semi-continuous System, Control & Software) by Application (Final Drug Product Manufacturing, Api Manufacturing) by End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Other End-users) and by Geography

Request free sample

The Asia Pacific pharmaceutical continuous manufacturing market is set to project a CAGR of 10.99% during the forecast period, 2021-2028. The growing investment in the pharmaceutical and biopharmaceutical industries and the thriving contract research organization (CRO) and contract manufacturing organization (CMO) are assessed to propel market growth.
asia-pacific-pharmaceutical-continuous-manufacturing-market

To know more about this report, request a free sample copy

The Asia Pacific pharmaceutical continuous manufacturing market growth analysis includes the assessment of Australia & New Zealand, India, China, Indonesia, Vietnam, South Korea, Japan, Thailand, and Rest of Asia Pacific. In China, several major pharmaceutical companies were facing setbacks, given the stringent regulatory environment. However, initiatives to promote health sector reforms and favorable policies are set to boost the fortunes of these companies. The country is also set to be the biggest emerging pharmaceutical market by 2022. The greatest economic burden after housing and education in China is healthcare. According to the Bio-Equip 2019 article, the country has a big bio-manufacturing market, with several Chinese bio companies targeting continuous bioprocessing. Such factors are set to drive the market growth in China.

In South Korea, there have been continuous efforts to pursue R&D productivity and effectiveness by the Korean R&D-based pharmaceutical companies. This is to tackle the disadvantageous R&D resources in comparison to advanced nations. The South Korean market’s primary advantage is the educated, competent, and experienced R&D manpower, and a strategic & dynamic nationwide collaboration between the public research organizations, academia, and industry. The country has also emerged as a vital contributor to global healthcare innovation. Such factors facilitate market growth in South Korea.

Pfizer Inc is a biopharmaceutical company that manufactures, markets, develops, and discovers, consumer healthcare products, vaccines, and medicines. The company provides products for cardiovascular, respiratory, ophthalmic diseases, gastrointestinal diseases, neurological problems, etc. Its operational regions include the Middle East, Asia Pacific, Africa, Europe, and the Americas.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      •    KEY DRIVERS
        • DEVELOPMENT OPPORTUNITIES IN UNTAPPED EMERGING MARKETS
        • INCREASED ADOPTION OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
        • RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING SYSTEMS
        • RISE IN PRODUCTION OF LARGE MOLECULES AND BIOLOGICS
        • INCREASE IN HEALTHCARE EXPENDITURE
      •    KEY RESTRAINTS
        • INCREASING CUSTOMER ANTICIPATIONS
        • LACK OF DEMAND FOR CONTINUOUS MANUFACTURING SYSTEMS IN UNDERDEVELOPED COUNTRIES
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCE ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY PRODUCT
      • INTEGRATED CONTINUOUS SYSTEM
      • SEMI-CONTINUOUS SYSTEM
      • CONTROL & SOFTWARE
    3. MARKET BY APPLICATION
      • FINAL DRUG PRODUCT MANUFACTURING
      • API MANUFACTURING
    4. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT MANUFACTURING ORGANIZATIONS
      • OTHER END-USERS
    5. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • CHINA
          • INDIA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA PACIFIC
    1. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • COPERION GMBH
        • ELI LILLY & COMPANY
        • GEA GROUP AG
        • GEBRUDER LODIGE MASCHINENBAU GMBH
        • GLATT GMBH
        • HOSOKAWA MICRON CORPORATION
        • KORSCH AG
        • LB BOHLE MASCHINEN + VERFAHREN GMBH
        • MUNSON MACHINERY COMPANY
        • PFIZER INC
        • SIEMENS HEALTHINEERS
        • SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
        • THERMO FISHER SCIENTIFIC INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL CONTINUOUS MANUFACTURING

    TABLE 2: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

    FIGURES LIST 

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, IN 2020

    FIGURE 6: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, IN 2020

    FIGURE 10: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, IN 2020

    FIGURE 13: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

    FIGURE 14: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 17: CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 18: INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 19: JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 20: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 21: SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: REST OF ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • CHINA
          • INDIA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA PACIFIC
    1. MARKET BY PRODUCT
      • INTEGRATED CONTINUOUS SYSTEM
      • SEMI-CONTINUOUS SYSTEM
      • CONTROL & SOFTWARE
    2. MARKET BY APPLICATION
      • FINAL DRUG PRODUCT MANUFACTURING
      • API MANUFACTURING
    3. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT MANUFACTURING ORGANIZATIONS
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now